Prior notification of a concentration (Case M.12301 – KOHLBERG / MONTAGU / TELEFLEX OEM BUSINESS) – Candidate case for simplified procedure
Date: 2026-03-31
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, health care, investment company, medical device, medical diagnosis, merger control, private limited company








C_202601978EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2026/1978


31.3.2026






Prior notification of a concentration
(Case M.12301 – KOHLBERG / MONTAGU / TELEFLEX OEM BUSINESS)
Candidate case for simplified procedure
(Text with EEA relevance)
(C/2026/1978)


1.   
On 23 March 2026, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Kohlberg & Co., LLC (‘Kohlberg’, United States),










—


Montagu Private Equity LLP (‘Montagu’, United Kingdom),










—


Teleflex OEM Business (United States).




Kohlberg and Montagu will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Teleflex OEM Business.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are the following:






—


Kohlberg is a US private equity firm. Kohlberg invests in various companies operating across the world, with a focus on the US. Kohlberg specialises in investments in healthcare and services companies,










—


Montagu, a limited liability partnership established under English law, is a private equity investor investing in a variety of sectors, including healthcare.






3.   
The business activities of the undertaking Teleflex OEM Business are the following:






—


Teleflex OEM Business designs, develops, and manufactures components and finished devices for other medical device companies. Its services include creating custom-engineered diagnostic and interventional components and devices,










—


Teleflex OEM Business is active in North America, Australia Pacific, EMEA, and Latin America.






4.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (2), it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


5.   
The Commission invites interested third parties to submit their possible observations on the proposed concentration to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.12301 – KOHLBERG / MONTAGU / TELEFLEX OEM BUSINESS
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu

Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  
            OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  
            OJ C 160, 5.5.2023, p. 1.


ELI: http://data.europa.eu/eli/C/2026/1978/oj
ISSN 1977-091X (electronic edition)